Cells help immune system tolerate friendly gut bacteria

Immune cells called group 3 innate lymphoid cells (ILC3s) play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

Neutralizing antibodies from single COVID-19 booster steadily decline

Neutralizing antibody levels against the original COVID-19 virus and omicron variants in vaccinated adults tend to decline by at least 15% per month after a single booster shot, a new study using serum from human blood samples suggests.

Depression among those caring for partners with dementia can start a decade before dementia diagnosis

Depressive symptoms and caregiving hours among older adults caring for partners with dementia can emerge up to 10 years before a routine screening detects the first signs of their partner's cognitive impairment, according to a University of Michigan study published in Medical Care.

Dosage of inpatient prism adaptation treatment for spatial neglect predicts outcomes of stroke rehabilitation

A team of stroke researchers found that the dosage of prism adaptation treatment correlated with improvement in post-stroke spatial neglect as well as in outcomes of rehabilitation. Their findings appeared in Neurorehabilitation and Neural Repair, published online on June 8, 2022.

Cap and invest policy could pay dividends for children's health

A cap-and-invest strategy to cut transportation-related carbon emissions could provide substantial health benefits to children in New York City, with greater benefits among Black and Hispanic children. The results of the study by researchers at Columbia University Mailman School of Public Health are published in Environmental Research.

Ultrasound color Doppler twinkling in commercial breast biopsy markers

According to ARRS' American Journal of Roentgenology (AJR), ultrasound color Doppler twinkling may aid the detection of certain biopsy markers in metastatic axillary nodes that resume normal morphology after neoadjuvant systemic therapy.

Artificial Intelligence tool could reduce common drug side effects

Research led by the University of Exeter and Kent and Medway NHS and Social Care Partnership Trust, published in Age and Ageing, assessed a new tool designed to calculate which medicines are more likely to experience adverse anticholinergic effects on the body and brain. These complications can occur from many -prescription and over-the-counter drugs which affects the brain by blocking a key neurotransmitter called acetylcholine. Many medicines, including some bladder medications, anti-depressants, medications for stomach and Parkinson's disease have some degree of anticholinergic effect. They are commonly taken by older people.